ロード中...
CAR-T cells and BiTEs in solid tumors: challenges and perspectives
Chimeric antigen receptor (CAR)-modified T cells and BiTEs are both immunotherapies which redirect T cell specificity against a tumor-specific antigen through the use of antibody fragments. They demonstrated remarkable efficacy in B cell hematologic malignancies, thus paving the way for their develo...
保存先:
| 出版年: | J Hematol Oncol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8054411/ https://ncbi.nlm.nih.gov/pubmed/33874996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-021-01067-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|